{
    "table_id": "finqa_e135421ae9",
    "source": "finqa",
    "original_metadata": {
        "source_dataset": "finqa",
        "document_id": "CME/2017/page_99.pdf-4",
        "pre_text_caption_evidence": [
            "in 2017 , the company granted 440076 shares of restricted class a common stock and 7568 shares of restricted stock units .",
            "restricted common stock and restricted stock units generally have a vesting period of two to four years .",
            "the fair value related to these grants was $ 58.7 million , which is recognized as compensation expense on an accelerated basis over the vesting period .",
            "dividends are accrued on restricted class a common stock and restricted stock units and are paid once the restricted stock vests .",
            "in 2017 , the company also granted 203298 performance shares .",
            "the fair value related to these grants was $ 25.3 million , which is recognized as compensation expense on an accelerated and straight-lined basis over the vesting period .",
            "the vesting of these shares is contingent on meeting stated performance or market conditions .",
            "the following table summarizes restricted stock , restricted stock units , and performance shares activity for 2017 : number of shares weighted average grant date fair value ."
        ],
        "question": "for the 2017 restricted common stock and restricted stock unit grants , assuming the average vesting period , what would annual compensation expense be in millions over the vesting period?"
    },
    "dimensions": {
        "rows": 5,
        "columns": 3
    },
    "schema": {
        "columns": [
            "",
            "number of shares",
            "weightedaveragegrant datefair value"
        ],
        "dtypes": {
            "": "object",
            "number of shares": "object",
            "weightedaveragegrant datefair value": "object"
        }
    }
}